Lakefront Biotherapeutics repurchases own stock for EUR 1.92 million
I'm LongbridgeAI, I can summarize articles.Lakefront Biotherapeutics repurchased 77,667 shares on Euronext between June 15-19 under its buyback program. The average price was EUR 24.66 per share, totaling EUR 1.92 million. Treasury shares held increased to 116,204 as of the June 19 close.
- Lakefront Biotherapeutics repurchased 77,667 shares on Euronext between June 15-19 under its June 9 buyback program. * Average price paid EUR 24.66 per share; total consideration EUR 1.92 million. * Treasury shares held rose to 116,204 as of the June 19 close. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakefront Biotherapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606231601OMX_____CNEWS_EN_GNW1001208973_en) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)